184 related articles for article (PubMed ID: 37901977)
1. [Anticoagulant therapy in left ventricular non-compaction: when, how and why].
Costantino J; Maria Ajmone F; Maggio E; Ballatore F; Manguso G; Ciaramella P; Galea N; Alfarano M; Severino P; Lavalle C; Vizza CD; Chimenti C
G Ital Cardiol (Rome); 2023 Nov; 24(11):866-871. PubMed ID: 37901977
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolism in heart failure: who should be treated?
Diet F; Erdmann E
Eur J Heart Fail; 2000 Dec; 2(4):355-63. PubMed ID: 11113711
[TBL] [Abstract][Full Text] [Related]
3. A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy.
Chimenti C; Lavalle C; Magnocavallo M; Alfarano M; Mariani MV; Bernardini F; Della Rocca DG; Galardo G; Severino P; Di Lullo L; Miraldi F; Fedele F; Frustaci A
ESC Heart Fail; 2022 Feb; 9(1):241-250. PubMed ID: 34918480
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation in patients with left ventricular systolic dysfunction and sinus rhythm: when?
Sivri N; Yetkin E; Tekin GO; Yalta K; Waltenberger J
Clin Appl Thromb Hemost; 2014 Oct; 20(7):729-34. PubMed ID: 23615290
[TBL] [Abstract][Full Text] [Related]
5. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction.
Baker DW; Wright RF
JAMA; 1994 Nov 23-30; 272(20):1614-8. PubMed ID: 7966873
[TBL] [Abstract][Full Text] [Related]
6. [Anticoagulant therapy in patients with dilated cardiomyopathy].
Gensini GF; Rostagno C
Ann Ital Med Int; 1998; 13(4):227-32. PubMed ID: 10349204
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological prevention of thromboembolism in patients with left ventricular dysfunction.
Thatai D; Ahooja V; Pullicino PM
Am J Cardiovasc Drugs; 2006; 6(1):41-9. PubMed ID: 16489847
[TBL] [Abstract][Full Text] [Related]
8. Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study.
Stöllberger C; Chnupa P; Abzieher C; Länger T; Finsterer J; Klem I; Hartl E; Wehinger C; Schneider B
Clin Cardiol; 2004 Jan; 27(1):40-6. PubMed ID: 14743856
[TBL] [Abstract][Full Text] [Related]
9. Lone atrial fibrillation and anticoagulant therapy.
More RS; Brack MJ; Gershlick AH
Clin Cardiol; 1993 Jun; 16(6):504-6. PubMed ID: 8358885
[TBL] [Abstract][Full Text] [Related]
10. [Anticoagulation in primary prevention of thromboembolism in advanced left ventricular dysfunction].
Siaplaouras S; Heisel A; Buob A; Jung J
Med Klin (Munich); 2001 May; 96(5):281-6. PubMed ID: 11395992
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in oral anticoagulation for atrial fibrillation.
Singh M; Adigopula S; Patel P; Kiran K; Khosla S
Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):395-407. PubMed ID: 20965952
[TBL] [Abstract][Full Text] [Related]
12. Real-world incidence of efficacy and safety outcomes in patients on direct oral anticoagulants with left ventricular systolic dysfunction at a tertiary referral center.
Tseng AS; William Schleifer J; Shen WK; McBane R; Mankad S; Esser H; Vucicevic D; Shamoun FE
Clin Cardiol; 2017 Dec; 40(12):1328-1332. PubMed ID: 29247519
[TBL] [Abstract][Full Text] [Related]
13. Thromboembolism in Heart Failure Patients in Sinus Rhythm: Epidemiology, Pathophysiology, Clinical Trials, and Future Direction.
Lin AY; Dinatolo E; Metra M; Sbolli M; Dasseni N; Butler J; Greenberg BH
JACC Heart Fail; 2021 Apr; 9(4):243-253. PubMed ID: 33714744
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice.
Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P
Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188
[TBL] [Abstract][Full Text] [Related]
15. Blood Coagulation Disorders in Heart Failure: From Basic Science to Clinical Perspectives.
Siniarski A; Gąsecka A; Borovac JA; Papakonstantinou PE; Bongiovanni D; Ehrlinder H; Giustozzi M; Guerreiro RA; Parker WAE
J Card Fail; 2023 Apr; 29(4):517-526. PubMed ID: 36632933
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.
Dries DL; Exner DV; Gersh BJ; Domanski MJ; Waclawiw MA; Stevenson LW
J Am Coll Cardiol; 1998 Sep; 32(3):695-703. PubMed ID: 9741514
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
[TBL] [Abstract][Full Text] [Related]
18. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation Therapy and NOACs in Heart Failure.
Thomas I; EncisoSilva J; Schlueter M; Greenberg B
Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation versus placebo for heart failure in sinus rhythm.
Lip GY; Wrigley BJ; Pisters R
Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
